Browse 25000 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
Close Date | Grant Title | Agency |
July 28th, 2024 |
ML/AI Tools to Advance Genomic Translational Research (MAGen) - Coordinating Center (UG3/UH3, Clinical Trials Not Allowed) |
National Institutes of Health |
July 28th, 2024 |
ML/AI Tools to Advance Genomic Translational Research (MAGen) - Development Sites (UG3/UH3 Clinical Trials Not Allowed) |
National Institutes of Health |
June 20th, 2024 |
FY 2024 Natural Gas Distribution Infrastructure and Safety Modernization Grant |
Pipeline and Hazardous Materials Safety Admin |
June 9th, 2024 |
Request for Information for USAID/Namibia Key Populations - Resilience, Innovation, Sustainability, and Empowerment (KP-RISE) |
South Africa USAID Pretoria |
May 7th, 2027 |
Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Not Allowed) |
National Institutes of Health |
May 7th, 2027 |
Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Required) |
National Institutes of Health |
July 3rd, 2024 |
Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) (P50 Clinical Trial Optional) |
National Institutes of Health |
May 7th, 2027 |
Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) |
National Institutes of Health |
May 7th, 2027 |
Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed) |
National Institutes of Health |
November 15th, 2024 |
Comprehensive Alcohol Research Centers (P60 Clinical trial Optional) |
National Institutes of Health |
November 15th, 2024 |
Specialized Alcohol Research Centers (P50 Clinical trial Optional) |
National Institutes of Health |
May 30th, 2024 |
Ensuring Social Protection by Empowering and building Resiliency for Adolescents, Nuclear families, Children, and caregivers affected by HIV/AIDS (ESPERANÇA) |
Mozambique USAID Maputo |
July 6th, 2024 |
USAID Integrated Health Systems Strengthening (IHSS) |
Agency for International Development |
November 1st, 2024 |
IVV S2S Testing - Do not submit |
IV V Test Agency |
May 29th, 2024 |
Market Day/Information Session for Expanding Local Partnerships for USAID Child Protection Activity |
West Africa USAID Ghana |
May 12th, 2024 |
USAID THRIVE PRE-APPLICATION CONFERENCE |
Nigeria USAID Abuja |
July 8th, 2024 |
Hazardous Materials Worker Health and Safety Training (U45 Clinical Trials Not Allowed) |
National Institutes of Health |
June 14th, 2024 |
Family Planning and Adolescent Reproductive Health Activity |
Philippines USAID Manila |
August 30th, 2024 |
Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional) |
National Institutes of Health |
October 17th, 2024 |
Type 1 Diabetes TrialNet Clinical Network Hub (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
|
May 31st, 2024 |
Anti-doping-2024 |
Office of National Drug Control Policy |
June 7th, 2024 |
Accelerating ChoiCe, Equity, and Sustainability for Services |
Agency for International Development |
June 10th, 2024 |
USAID/Ethiopia health Security Activity |
Ethiopia USAID Addis Ababa |
August 13th, 2024 |
Advancing HIV service delivery through pharmacies and pharmacists (R21 Clinical Trial Optional) |
National Institutes of Health |
August 13th, 2024 |
Advancing HIV service delivery through pharmacies and pharmacists (R01 Clinical Trial Optional) |
National Institutes of Health |
October 17th, 2024 |
Coordinating Center for Type 1 Diabetes TrialNet (U01 Clinical Trial Required) |
National Institutes of Health |
April 5th, 2027 |
Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Required) |
National Institutes of Health |
July 10th, 2024 |
Center for Maternal and Child Health Medicaid Partnerships |
Health Resources and Services Administration |
May 7th, 2027 |
Independent Scientist Award (Parent K02 Independent Basic Experimental Studies with Humans Required) |
National Institutes of Health |
April 28th, 2027 |
NHLBI Emerging Investigator Award (EIA) (R35 Clinical Trial Optional) |
National Institutes of Health |
April 28th, 2027 |
NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional) |
National Institutes of Health |
April 5th, 2027 |
Small Business Transition Grant for New Entrepreneurs (R41/R42 Clinical Trial Required) |
National Institutes of Health |
April 5th, 2027 |
Small Business Transition Grant for New Entrepreneurs (R41/R42 Clinical Trial Not Allowed) |
National Institutes of Health |
October 9th, 2024 |
Engineering Durable HIV Vaccine Responses (ENDURE) (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
May 7th, 2027 |
Midcareer Investigator Award in Patient-Oriented Research (Parent K24 - Independent Basic Experimental Studies with Humans Required) |
National Institutes of Health |
May 7th, 2027 |
Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Not Allowed) |
National Institutes of Health |
May 7th, 2027 |
Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Required) |
National Institutes of Health |
April 5th, 2027 |
Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Not Allowed) |
National Institutes of Health |
March 10th, 2025 |
Understanding the Intersection of Social Inequities to Optimize Health and Reduce Health Disparities: The Axes Initiative (R01 Clinical Trial Optional) |
National Institutes of Health |
July 24th, 2024 |
Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 - Clinical Trial Not Allowed) |
National Institutes of Health |